martes, 2 de febrero de 2016

National Guideline Clearinghouse | Guidelines by Topic: Macular Degeneration

National Guideline Clearinghouse (NGC)
National Guideline Clearinghouse | Guidelines by Topic: Macular Degeneration

Guidelines by Topic

Macular Degeneration (10)

1-10 of 10  
 
1. 
Food and nutrition for older adults promoting health and wellness (FNOA). 2012. NGC:009563
Academy of Nutrition and Dietetics - Professional Association. View all guidelines by the developer(s)
2. 
Aflibercept solution for injection for treating wet age-related macular degeneration. 2013 Jul. NGC:009971
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
3. 
Ranibizumab for treating visual impairment caused by macular oedema secondary to retinal vein occlusion. 2013 May. NGC:009895
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
4. 
Occupational therapy practice guidelines for older adults with low vision. 2013. NGC:010073
American Occupational Therapy Association, Inc. - Professional Association. View all guidelines by the developer(s)
5. 
Dexamethasone intravitreal implant for treating diabetic macular oedema. 2015 Jul 22. NGC:010778
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
6. 
Aflibercept for treating diabetic macular oedema. 2015 Jul. NGC:010771
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
7. 
Aflibercept for treating visual impairment caused by macular oedema secondary to central retinal vein occlusion. 2014 Feb. NGC:010285
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
8. 
Evidence-based clinical practice guideline: eye care of the patient with diabetes mellitus. 1993 (revised 2014). NGC:010318
American Optometric Association - Professional Association. View all guidelines by the developer(s)
9. 
Ranibizumab for treating diabetic macular oedema (rapid review of technology appraisal guidance 237).2013 Apr. NGC:009630
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
10. 
Fluocinolone acetonide intravitreal implant for the treatment of chronic diabetic macular oedema after an inadequate response to prior therapy. 2013 Jan. NGC:009631
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
1-10 of 10  

No hay comentarios:

Publicar un comentario